Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-economic Comparison of Daptomycin vs. Vancomycin Based Regimens

计划入组 6 人 · 首次发布于 2010 年 5 月 31 日

"CuraMed" and "Curamin" in Osteoarthritis

计划入组 179 人 · 首次发布于 2015 年 3 月 17 日

The ORIGIN-FH Study

计划入组 70 人 · 首次发布于 2026 年 3 月 13 日

anti-inflammatory program, MuriGen

Del-1 therapeutics (Urigen Pharmaceuticals)

LC autologous blood origin T lymphocyte

CURAGEN CORPORATION

United States

CURTIN UNIVERSITY

Australia

Aurigen Medical Ltd.

Ireland

RNAi Therapeutics Expand Beyond the Liver as siRNA Drug Development Accelerates

Indian-Origin Scientists Develop Weekly Injectable for Parkinson's Disease Treatment

Atacicept Shows Promise in Slowing Kidney Function Decline in IgA Nephropathy